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Damage  to the mucous  membrane  is a  serious  issue  associated  with  chemotherapy.  Gastrointestinal
(GI)  toxicity  is  complex  and  multistep  process  and  unregulated  production  of  reactive  oxygen  species
(ROS)  and  inﬂammatory  mediators  play  vital  role  in  the  development  of GI  toxicity.  In the  present  study
we  have  investigated  the attenuating  potential  of  vitamin  C (vit.  C)  on  5 ﬂuorouracil  (5-FU)  induced
GI  toxicity  by  targeting  oxidative  stress  and  inﬂammatory  markers  in Sprague  Dawley  (SD) rats.  Rats
were  gavaged  with  vit.  C  (500  mg/kg  b. wt.)  or vehicle  daily  (day  1–10)  and  were  given  intraperitoneal
injection of 5-FU  (150  mg/kg  b. wt.) or saline  (control)  on day  8 to  induce  mucositis.  We  found  that  vit. C
supplementation  attenuated  5-FU  induced  lipid  peroxidation,  myeloperoxidase  (MPO)  activity,  activation
of NF-kB  and  expression  of  COX-2.  Histological  observations  further  supported  the  protective  potential  of
vit. C  against  5-FU  induced  intestinal  anomalies  such  as  neutrophil  inﬁltration,  loss  of cellular  integrity,
villus  and  crypt  deformities.  Thus  the biochemical,  molecular  and  histological  ﬁndings  of the present
study  demonstrate  that oxidative  stress  and  inﬂammation  play  vital  role in  5-FU  induced  GI toxicity  and
the  inhibitory  potential  of  vit. C is may  be due  to the  modulation  of  oxidative  stress,  activation  of  redox
sensitive  transcription  factor  and  also  its  downstream  target  molecules.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
Gastrointestinal damage is one of the important adverse
ffects of anti-neoplastic drug on the cancer patients undergoing
hemotherapy characterized by ulceration of the entire gastroin-
estinal tract. Unbearable and painful symptoms such as pain,
ausea, vomiting, diarrhoea, heart burden and constipation devel-
ps [15,26]. Mucositis is also known to increase the mortality,
orbidity and poses a huge economic burden on the patient receiv-
ng chemotherapy [11,17].
A Number of anti-neoplastic drugs are used for the chemother-
py. 5-Fluorouracil (5-FU) is the most commonly used chemother-
peutic drug for the treatment of various forms of cancer because
f its ability to improve tumor-free status and survival rates
24]. However, more than ﬁfty percent of patients receiving 5-FU
∗ Corresponding author at: Research Center, Prince Sultan Military Medical City,
O Box 7897 (777-S), Riyadh 11159, Saudi Arabia. Tel.: +966 1 4777714x25100;
ax:  +966 1 4786601.
E-mail address: abdulrahman.alasmari@gmail.com (A.K. Al-Asmari).
ttp://dx.doi.org/10.1016/j.toxrep.2015.06.006
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
develops mucositis in addition to other gastrointestinal (GI) com-
plications because 5-FU is not speciﬁcally acts on cancer or tumor
cells, but also normal proliferating cells which ultimately result into
the severe toxicity [34].
5-Fu induced GI toxicity is a complex and multistep phe-
nomenon. It includes direct damage to cellular macromolecules,
over production of harmful reactive oxygen species (ROS), alter-
ation of various signaling pathways, over expression of inﬂamma-
tory agants like nuclear factor kappa-B (NF-kB), cyclooxygenase-2
(COX-2) and proinﬂammatory cytokines [34].
While use of chemotherapeutic drugs for the treatment of can-
cer is one of the commonly used approaches by the clinicians but
this approach is associated with serious adverse effects on patients
and GI toxicity is one of them. Available measures to treat GI tox-
icity are not adequate and mostly symptomatic. To overcome this
potential problem and to make chemotherapeutic measures more
effective attention has been given to combination therapy with
natural or synthetic agents to reduce the overall burden of can-
cer worldwide such as targeted intervention, antioxidants, herbal
products, growth factors and anti-inﬂammatory agents [20,22].
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Fig. 1. Effect of vit. C and 5-FU on MPO  activity of small intestine. Bars represent the
mean ± SEM per treatment group (n = 6). **p  < 0.001 shows signiﬁcant difference in
the  animals treated with only 5-FU as compared with vehicle treated control ani-
mals. #p < 0.05, shows the statistically signiﬁcant difference in the animals treated
with vit. C along with 5-FU when compared with the animals injected with 5-FU
only.
Fig. 2. Effect of vit. C and 5-FU on MDA  level of small intestine. Bars represent the
mean ± SEM per treatment group (n = 6). ***p < 0.001 shows signiﬁcant difference inA.K. Al-Asmari et al. / Toxic
Vit. C, a hydrophilic vitamin, is a very important cellular antiox-
dant and radical scavenger which protects cellular architecture
nd maintains homeostasis from different toxic insults. Vit. C
as well known antioxidant, anti-inﬂammatory, anti-carcinogenic,
mmunomodulatory, antimicrobial, cytoprotective and many other
eneﬁcial properties [3,9,14,16]. Various ﬁndings demonstrate that
it. C has strong attenuative characteristics against the pathogene-
is of various diseases and their complications [5,13,33,40].
Taking the above mentioned facts into account, in the present
tudy we have investigated the preventive potential of vit. C on 5-
U induced GI toxicity in Sprague Dawley (SD) rats by analyzing the
iochemical, molecular and histological parameters.
. Materials and methods
.1. Chemicals and other reagents
Hexadecyl trimethyl ammonium bromide (HTAB), hydrogen
eroxide, potassium di-hydrogen phosphate, di-potassium hydro-
en phosphate, o-dianisidine dihyderochloride, vitamin C, tris and
ween 20 were purchased from Sigma–Aldrich. 5-Fluorouracil was
upplied by ICN Biomedicals Inc., Ohio, USA. Trichloroacetic acid
TCA), thiobarbituric acid (TBA) and all other reagents used were of
nalytical grade.
.2. Animals
Male Sprague Dawley (SD) rats (150–200 g), 6–8 weeks old,
ere obtained from animal house facility of research center, Prince
ultan Military Medical City (PSMMC), Riyadh, Saudi Arabia. All
nimals were housed in the animal care facility under room tem-
erature at 22–25 ◦C with 12 h light/12 h dark cycle in standard
ages and were given free access to standard laboratory diet and
ater ad libitum. The animals received humane care in accor-
ance with the Guide for the Care and Use of Laboratory Animals,
ublished by the ethical scientiﬁc research committee of PSMMC,
iyadh, Saudi Arabia.
.3. Treatment regimen
Rats were randomly divided in to four groups. Each group
omprises of six animals. All four group animals received nor-
al  standard diet and water throughout the experimental period.
nimals in group one received only vehicle (0.9% saline intraperi-
onially) on day eighth and serve as the control group. Animals
f the group second were given single intraperitoneal injection
f 5-FU (150 mg/kg b. wt.) on day eight and served as positive
ontrol. Animals in group third were given oral gavage of vit. C
500 mg/kg. b. wt.) for ten days (day one to day ten) and single
ntraperitoneal injection of F-5U (150 mg/kg b. wt.) on day eighth.
nimals of the group four received only oral gavage of vit. C
500 mg/kg. b. wt.) for ten days. All four sets (group) of experimen-
al animals were sacriﬁced under mild anaesthesia 72 h after 5-FU
njection: that is on day eleven.
.4. Tissue processing
At the termination of treatments, animals were sacriﬁced by
ervical dislocation under mild anaesthesia. Small intestine was
xcised and washed with ice cold sodium chloride (0.9). A piece
f small intestinal tissue was preserved in 10% neutral buffered
ormalin for histological observation..4.1. Myeloperoxidase activity
MPO  activity was assayed by the method of Bradley et al. [1].
issue homogenate was  prepared in 50 mM potassium phosphateonly  5-FU treated animals when compared with vehicle treated animals. #p < 0.05,
shows the statistically signiﬁcant difference in the animals treated with vit. C along
with 5-FU when compared with the animals injected with 5-FU only.
buffer (pH 6.0) containing 0.5% hexadecyl- trimethylammonium
bromide. Samples were subjected to three cycles of sonication
freezing-thawing procedures followed by spinning at 14,000 rpm
for 25 min  at 4 ◦C.In 0.1 ml  of supernatant, MPO  activity was mea-
sured using 2.9 ml  phosphate buffer (50 mM,  pH 6.0) containing
0.167 mg/ml  O-dianisidine dihydrochloride and 1% hydrogen per-
oxide as substrates, at 460 nm over three min. MPO activity was
expressed in a unit which is deﬁned as the quantity of enzyme
degrading 1  mol  of H2O2 / min  at 25 ◦C. The result was  expressed
as Units/min/gm.
2.4.2. Lipid peroxidation
The rate of lipid peroxidation (LPO) was determined according
to the method of Utley et al., [35] by estimating malondialde-
hyde (MDA) with slight modiﬁcation. Brieﬂy, 0.25 ml of tissue
homogenate (in 10% phosphate buffer, pH 7.4) was  incubated
at 37 ◦C in water bath. After an hour of incubation, 0.25 ml  of
TCA(5%) and 0.5 ml  of TBA (0.67%) was added to the sample and
centrifuged at 3000 × g for 10 min. The clear supernatant was  trans-
ferred to another tube and placed in a boiling water bath for 10 min.
Finally, the tubes were cooled and the color intensity was  mea-
sured was  recorded at 535 nm.  The malondialdehyde concentration
in the samples was  calculated using the molar extinction coefﬁ-
cient of 1.56 × 10–5 M-1  cm-1 for MDA-TBA colored complex and
expressed as mol  of malondialdehyde formed/g tissue.
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Fig. 3. Effect of vit. C on 5-FU induced NF-kB activation in intestine. Representative photomicrographs (magniﬁcation 40×;  scale bar-100 m)  depicting immunohistochemical
activation of NF-kB, (A) vehicle treated animals showing minimal or no staining, (B) 5-FU treated animals showing remarkably high intense staining as shown by arrows,
(C)  administration of vit. C + 5-FU treated animals showing moderate staining (arrows) and (D) vit. C treated animals showing minimal or no staining. Brown color indicates
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.5. Alcian blue-safronin staining for mucin analysis
Sections of 5 m from parafﬁn embedded intestinal tissue were
xed on poly-l-lysine coated glass slides. Next, were dewaxed in
ylene and rehydrated through graded series of ethanol to water.
he staining was  performed in 1% Alcian blue prepared in 3% acetic
cid solution (pH 2.5) for 30 min. To avoid any non-speciﬁc stain-
ng, a quick dip of the slides were given in 3% acetic acid solution.
fter thorough washing of slides, sections were counterstained
ith 1% safronin followed by washing and dehydration of the slides
n alcohol and xylene. Slides were mounted using DPX mountant
nd observed under light microscope (BX53 microscope, Olympus,
apan).
.6. Immunohistochemical detection of NF-kB and COX-2
xpressionIntestine sections of 5 m thickness were cut onto poly l-Lysine
oated glass slides. Sections were deparafﬁnized 3 times (5 min
ach) in xylene followed by dehydration in graded ethanol andterpretation of the references to color in this ﬁgure legend, the reader is referred to
ﬁnally rehydrated in running tap water. For antigen retrieval, the
sections were boiled in 10 mM  citrate buffer (pH 6.0) for 15–20 min.
Next, the sections were incubated with protein block (abcam) for
10 min  at room temperature followed by TBST wash. Normal goat
serum (ab138478) was  used as the blocker for 2 h prior to primary
antibodies treatment for overnight at 4 ◦C. Further processing was
done by using Mouse and Rabbit speciﬁc HRP (ABC) Detection IHC
kit (ab93697) from Abcam. The peroxides complex was  visualized
with 3,3-diaminobenzidine. Lastly the slides were counterstained
with haematoxylin, cleaned in water, xylene and ethanol. After DPX
mounting microscopic (BX53 microscope, Olympus, Japan) analy-
sis was  done. Primary antibodies were rabbit anti-NF-kB p105/p50
(phosphor S927) (dilution1:150, Abcam, ab131493) and rabbit anti-
COX-2 (Abcam, ab21704).
Evaluation of immunohistochemical expression of NF-kB and
COX-2 was done by two  independent observers on a binocular
upright microscope (Olympus BX 53, Japan) randomly at least
in six different focuses per slide. For evaluation of the immuno-
histochemical expression of NF-kB and COX-2, we used a score
(immuno-reactive) including intensity and quantity of stained cells.
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Fig. 4. Effect of vit. C on 5-FU induced expression of COX-2 in small intestine. Representative photomicrographs (magniﬁcation 20×;  scale bar-100 m))  depicting immuno-
histochemical activation of COX-2, (A) vehicle treated animals showing minimal or no immunopositive staining, (B) 5-FU treated animals showing remarkable intense staining
a nd (D
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is  shown by arrows, (C) Vit. C + 5-FU treated animals showing low staining (arrow) a
mmunopositive staining of COX-2 and blue color depicts haematoxylin staining. (F
he  web version of this article.)
ntensity of the staining was scored as negative or no staining
0), weak but detectible (1), moderate or distinct (2+) or strong
r intense (3) by eyes in a blinded fashion. The average number
f cells used for the analysis of NF-kB and COX-2 staining were
pproximately ﬁve hundred. Thereafter, we counted the number of
ositively stained cells and percentage of NF-kB and COX-2 stained
ells were scored on a scale of 0–4 (0 for <5% immunopositive
ells; 1 for <10% immunopositive cells; 2 for 10–50% immunopos-
tive cells; 3 for 51–80% immunopositive cells; or 4 for >80%
mmunopositive cells). Immunoreactive score was  calculated by
ultiplying the intensity and number of stained cells.
.7. Histological analysisFor histopathological studies, a portion from small intestine
as ﬁxed in freshly prepared 10% neutral-buffered formalin (NBF)
mmediately after sacriﬁce. Then, each portion of small intestine) Vit. C only treated animals showing minimal or no staining. Brown color indicates
erpretation of the references to color in this ﬁgure legend, the reader is referred to
tissue was  embedded in parafﬁn wax and blocks were prepared.
Sections of 5 m thickness were cut on to poly-l-lysine coated
microscopic slides and stained with haematoxylin and eosin (H&E).
Histological changes were monitored under light microscope (BX53
microscope, Olympus, Japan) at least in six different regions.
We have also assessed the role of vit. C in healing the anti-
neoplastic drug induced intestinal damage by measuring the villus
hight. Intestinal epithelial cell renewal was  also assessed by the
microscopic analysis of mitotic cells (mitotic ﬁgures). All the anal-
ysis was  performed randomly at least in six different regions per
section and the microscopy analysis was  double-blinded.
2.8. Statistical analysisThe data from individual treatment groups are presented as the
means ± standard error of the mean (SEM). Differences between
groups were analyzed by using one way analysis of variance
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(ig. 5. Effect of vit. C treatment on 5-FU induced mucin depletion in small intesti
ucin  staining, (A) vehicle treated animals showing normal mucin layer (arrows), (
 + 5-FU treated animals showing moderate mucin depletion (arrows) and (D) Vit. C
ANOVA) followed by Tukey–Kramer multiple comparisons test.
ata were considered statistically signiﬁcant when the p values
ere p < 0.05.
. Results
.1. Vit. C inhibits 5-FU induced intestinal MPO  activity
MPO  is one of the key abundant enzymes secreted by inﬂam-
atory cells and known as important marker of inﬂammation. We
bserved sigﬁcantly increased intestinal MPO  activity in only 5-FU
reated animals as compared to only vehicle treated control ani-
als (p < 0.01). However, treatment with vit. C in addition to 5-FU
igniﬁcantly attenuated MPO  activity as compared to only 5-FU
reated animals (p < 0.05). No signiﬁcant difference was observed in
PO  activity between vehicle treated and only vit. C administered
nimals (Fig. 1).
.2. Vit. C abrogates 5-FU induced intestinal lipid peroxidation
MDA level)
Attenuative potential of vit.C was further strengthened by MDA
evel estimation. We  found that there was a signiﬁcantly increased
evel of MDA  in 5-FU treated animals as compared to vehicle treated
nimals (p < 0.001). Supplementation with vit. C along with 5-FU
as showed signiﬁcant reduction of MDA  level as compared to 5-
U treated animals (p < 0.05). There was no signiﬁcant difference
bserved in MDA  level between vehicle and vit. C treated animals
Fig. 2).presentative photomicrographs (magniﬁcation 20×; scale bar-100 m) depicting
U treated animals showing complete mucin depletion as shown by arrows, (C) Vit.
 treated animals showing normal mucin layer.
3.3. Vit. C modulates the 5-FU induced expression of NF-kB
(p105/p50) and COX-2
Modulatory action of vit.C was further evaluated by checking
the expression of molecular markers of pathogenesis. Immuno-
histochemical staining for the expression of NF-kB and COX-2 in
small intestine has been shown in Figs. 3 and 4, respectively. Ele-
vated expression of NF-kB and COX-2 in small intestine sections
was observed to the animals injected with only 5-FU as com-
pared to vehicle treated animals. While vit. C treated animals have
showed reduce immunopositive staining of NF-kB and COX-2 as
compared to only 5-FU treated animals. However, there was no
marked difference in the intensity of brown color was observed
in the immunostaining of NF-kB and COX-2 in only vit. C treated
animals as compared to vehicle treated animals. For immunohisto-
chemical analyses, brown color indicates speciﬁc immunostaining
of NF-kB and COX-2 and light blue color indicates haematoxylin
staining. Original magniﬁcation: 20× and 40× for COX-2 and NF-kB,
respectively.
3.4. Vit. C attenuates mucin depletion in small intestine after
5-FU injection
Mucin plays an important role in proper functioning of small
intestine. We  found that 5-FU injection causes complete deple-
tion of mucin in small intestine as compared to vehicle treated
animals. However, supplementation of vit. C with 5-FU reduced
the level of mucin depletion when compared with only 5-FU
treated animals. However, there is no depletion of mucin layer
was observed in only vit. C treated animals as compared to
vehicle treated control animals (Fig. 5). Original magniﬁcation:
20×.
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epicting histology analysis, (A) only vehicle treated animals showing normal histo
reated  animals showing suppressed histological alterations and (G) Vit. C only tre
agniﬁed view (10× magniﬁcations) of the insets (A, C, E & G) showed at the lower
.5. Vit. C abrogates 5-FU induced histological ailments in small
ntestine
Modulatory potential of vit.C was further supported by histo-
ogical observation in small intestine. Photo-micrographic analysis
f small intestine depicts that 5-FU treatment resulted in massive
nﬂammatory response characterized by increased inﬂammatory
ell inﬁltration in both mucosal and sub-mucosal regions. Addi-
ionally, massive deformities of villi including shortening of height,
oss and atrophy, and marked disorganization of crypts and accu-
ulation of ﬂuids was also observed in 5-FU treated animals as
ompared to vehicle treated animals. Supplementation of vit.C
long with 5-FU attenuated the above mentioned histological
eformities of small intestine induced by 5-FU injection. There was
o remarkable histological change observed in the animals treated
ith only vit.C and also in the animals treated with vehicle (Fig. 6).
riginal magniﬁcation: 4× & 10×.
5-FU administration in rats showed intense cell degeneration or
roliferation impairment as reﬂected by the mitotic cells (mitotic
odies) analysis in the crypts of intestine. Number of apoptotic bod-
es and loss of usual proliferating cells were seen in the intestinale. Representative photomicrographs (magniﬁcation 4× & 10×; scale bar-100 m)
(C) 5-FU treated animals showing marked histological deformities, (E) Vit. C + 5-FU
animals showing normal histology. Insets (B, D, F & H) at the upper panel show a
l (4× magniﬁcations).
crypts of 5-FU injected rats. Vit. C supplementation attenuated the
impairment of cell regeneration as demonstrated by the presence
of normal mitotic cells and suppressed apoptosis (Fig. 7).
4. Discussion
The ﬁndings of this study showed that vit. C has strong
preventive potential on gastrointestinal ailments caused by anti-
neoplastic drug 5-FU as evident by its inhibitory action on
biochemical, molecular and histological markers.
GI mucositis is one of the most frequent dose limiting and costly
toxic effects of cancer therapy because it causes major hindrance in
tumor treatment and also play vital role in cancer related morbid-
ity and mortality [11,17,26]. Although, extensive efforts have been
made to explore the pathogenesis, the underlying mechanism of
mucositis is not fully revealed. Gastro intestinal damage induced
by anti-neoplastic drugs is a multistep process which includes
direct DNA damage to normal intestinal proliferating cells, over
production of reactive oxygen species, up regulation of different
transcription factors, ulceration and healing [31]. Reactive oxygen
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Aig. 7. Showing the mitotic and apoptotic bodies of the H & E stained small intest
ormal  mitotic cells (arrow), (B) 5-FU treated animals depicting no intact mitotic cel
enewal of mitotic cells (arrow) and suppressed apoptotic bodies (arrow head) and
pecies and inﬂammatory mediators are the key elements respon-
ible for the initial injuries to intestinal mucosa [22,32].
Anti-neoplastic drug induced oxidative stress plays major role in
he development of most of the adverse effects including mucositis
ia modulating different signaling pathways which ultimately lead
o abnormal cellular integrity and functioning [6,27,32,39]. Here in
he current study we observed the elevated level of oxidative stress
arker after 5-FU injection which supports the previous ﬁndings.
ere we found that administration with vit. C inhibits 5-FU induced
ipid peroxidation, a well-known marker of oxidative stress sug-
esting that supplementation with antioxidant could enhance the
herapeutic potential of chemotherapy.
Since, role of redox sensitive transcription factors like NF-kB
ave been well explored in the development of adverse effects
ssociated with chemotherapy so, in the current study we have
nvestigated the modulatory potential of vit. C on nuclear translo-
ation of NF-kB.
NF-kB, a ubiquitous redox-sensitive transcription factor which
egulates the functioning of almost all the cellular activities includ-
ng the genes controlling inﬂammation, apoptosis, cell division,
ifferentiation and development [37]. In normal or resting state NF-
B localized in cytoplasm but under stress conditions it translocates
nto nucleus and regulates the expression of downstream targets. A
umber of stimuli can activate the nuclear translocation of NF-kB.
ctivation of NF-kB modulates the expression of more than hun-ypts (magniﬁcation 40×,  scale bar 100 m).  (A), vehicle treated animals showing
 number of apoptotic bodies (arrow head), (C) Vit. C + 5-FU treated animals showing
ly Vit. C treated animals showing normal mitotic cells with no apoptotic bodies.
dred genes resulting in accumulation of various type of biologically
active proteins including COX-2 and proinﬂammatory cytokines
and ultimately leads to gastrointestinal damage [4,29,30,32].
Here we have observed that administration of vit. C has dimin-
ished the activation of NF-kB which reﬂects the anti-inﬂammatory
potential of vit. C. Previous research ﬁndings also support the mod-
ulatory effect of vit. C on NF-kB activation [2,28,36]. The exact
underlying mechanism about the modulatory action of vit.C on the
nuclear translocation of NF-kB is not well explained. NF-kB is a
redox sensitive transcription factor and alteration in redox state
leads to its activation. Vit. C has well known anti-oxidant poten-
tial and the modulatory action of vit.C on NF-kB may  be due to its
quenching effect on ROS and so the inhibition of IkB kinase (IKK)
activation which lead to dissociation of IkB (Inhibitor of kB).
Inhibition of COX-2, a stress response protein, by vit. C
administration further supports its preventive potential against
anti-neoplastic drug induced gastrointestinal toxicity. Role of COX-
2 has been well documented in the development of most of
the chronic human diseases and pathological conditions. Elevated
expression of COX-2 in the intestine was  detected after 5-FU injec-
tion which is in agreement with previous ﬁndings [12]. Since COX-2
is a stress response protein, a number of stimuli such as ROS,
proinﬂammatory cytokines generated due to 5-FU also up regu-
late the expression of COX-2 [21]. Up regulation of COX-2 leads to
overproduction of prostaglandins and expression of matrix met-
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lloproteinases (MMPs) which results in breakdown of collagen,
pithelial basement membrane, edema formation and ultimately
issue injury [8,32,38]. Here we found that vit. C administration
as suppressed 5-FU induced COX-2 expression in small intes-
ine which support it’s anti-inﬂammatory and thus anti-mucositis
otential which is in accordance with previous ﬁndings [18,23].
Evaluation of MPO  activity further supported the anti-
nﬂammatory potential of vit.C. MPO  is a key proinﬂammatory
nzyme secreted by inﬂammatory cells play important role in
ellular protection from microbial infection by forming hypochlor-
us acid/hypochlorite and other toxic moieties. Various research
ndings demonstrate that elevated MPO  activity is linked with
evelopment of most of the chronic human diseases [7,19,25].
emarkably increased MPO  activity after 5-FU injection suggests
ts role in the gastrointestinal damage and vit. C supplementation
ttenuated the elevated MPO  activity which shows its strong anti-
nﬂammatory and anti-oxidant potential.
Histopatholical observations further supported the attenuative
otential of vit.C against anti-neoplastic drug 5-FU induced intesti-
al damage. Massive histological deformities like loss of villus
rchitecture including shortening of villi with blunting and fusion,
isorganization of crypts, abundance of inﬂammatory cells, cellular
oss and impairment of cellular renewal or regeneration was  seen
n small intestine after 5-FU injection. While vit.C administration
uppressed 5-FU induced histological deformities and this action
f vit.C supports its preventive potential. In addition, biochemical
nd molecular ﬁndings also supports the histological observations.
he overall ﬁndings of the current study provides important clue
bout the attenuative role of vit.C against 5-FU induced GI toxicity.
issection of deep underlying molecular mechanism is important
o further strengthen the data for preventive potential of vit. C by
tudying various redox sensitive transcription factors, cytokines,
poptotic and anti-apoptotic markers.
In conclusion, ﬁndings of the current study demonstrate that
it.C has shown strong potential against antineoplastic drug 5-FU
nduced gastrointestinal damage. Additional studies are warranted
o further support the attenuative potential of vit.C against the anti-
eoplastic drug 5-FU induced gastrointestinal damage by studying
eep molecular mechanisms.
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